StockData
Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc. (CODX) stock

CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$0.20−0.03 (-12.85%)

Close on Nov 17, 2026Market cap $1.23MP/E –Yield –

Co-Diagnostics net income

Net income is the profit left for shareholders after every expense, interest and tax.

Co-Diagnostics's net income for the twelve months ending Jun 30, 2026 was -$47.06M. For fiscal 2025 it was -$46.90M. The highest annual figure on record is $42.48M in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$46.90M–
FY2024Dec 31, 2024-$37.64M–
FY2023Dec 31, 2023-$35.33M–
FY2022Dec 31, 2022-$14.24M-138.8%
FY2021Dec 31, 2021$36.66M-13.7%
FY2020Dec 31, 2020$42.48M–
FY2019Dec 31, 2019-$6.20M–
FY2018Dec 31, 2018-$6.27M–
FY2017Dec 31, 2017-$6.96M–
FY2016Dec 31, 2016-$1.93M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.28M–
Q1 FY2026Mar 31, 2026-$9.14M–
Q4 FY2025Dec 31, 2025-$25.75M–
Q3 FY2025Sep 30, 2025-$5.89M–
Q2 FY2025Jun 30, 2025-$7.73M–
Q1 FY2025Mar 31, 2025-$7.53M–
Q4 FY2024Dec 31, 2024-$11.03M–
Q3 FY2024Sep 30, 2024-$9.70M–
Q2 FY2024Jun 30, 2024-$7.60M–
Q1 FY2024Mar 31, 2024-$9.31M–
Q4 FY2023Dec 31, 2023-$14.68M–
Q3 FY2023Sep 30, 2023-$5.98M–
Q2 FY2023Jun 30, 2023-$8.92M–
Q1 FY2023Mar 31, 2023-$5.76M-149.1%
Q4 FY2022Dec 31, 2022-$21.91M-392.1%
Q3 FY2022Sep 30, 2022-$1.36M-111.9%
Q2 FY2022Jun 30, 2022-$2.69M-127.5%
Q1 FY2022Mar 31, 2022$11.71M+48.3%
Q4 FY2021Dec 31, 2021$7.50M-41.5%
Q3 FY2021Sep 30, 2021$11.48M-27.1%
Q2 FY2021Jun 30, 2021$9.79M-34.8%
Q1 FY2021Mar 31, 2021$7.90M–
Q4 FY2020Dec 31, 2020$12.81M–
Q3 FY2020Sep 30, 2020$15.73M–
Q2 FY2020Jun 30, 2020$15.01M–
Q1 FY2020Mar 31, 2020-$1.07M–
Q4 FY2019Dec 31, 2019-$1.74M–
Q3 FY2019Sep 30, 2019-$1.75M–
Q2 FY2019Jun 30, 2019-$1.34M–
Q1 FY2019Mar 31, 2019-$1.37M–
Q4 FY2018Dec 31, 2018-$1.95M–
Q3 FY2018Sep 30, 2018-$1.64M–
Q2 FY2018Jun 30, 2018-$1.37M–
Q1 FY2018Mar 31, 2018-$1.31M–
Q4 FY2017Dec 31, 2017-$1.50M–
Q3 FY2017Sep 30, 2017-$3.89M–
Q2 FY2017Jun 30, 2017-$855.01K–
Q1 FY2017Mar 31, 2017-$705.74K–
Q4 FY2016Dec 31, 2016-$525.25K–
Q3 FY2016Sep 30, 2016-$449.95K–

More Co-Diagnostics figures

See a number that looks wrong?